Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

Endoscopic Procedures I: Esophagogastroduodenoscopy

An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of a novel 4.5F electrohydraulic lithotripsy probe for complex biliary stone fragmentation: a case series.

iGIE : innovation, investigation and insights·2026
Same author

Commentary.

Endoscopy·2026
Same author

A Pilot Study of Corticosteroid Treatment for Achalasia-Variant Esophagogastric Junction Outflow Obstruction.

Gastro hep advances·2026
Same author

Three-dimensional ERCP with cone-beam computed tomography: Novel approach to managing complex biliary strictures.

Endoscopy international open·2026
Same author

American Society for Gastrointestinal Endoscopy standards for fellowship training in peroral endoscopic myotomy.

Gastrointestinal endoscopy·2026
Same author

Role of prophylactic antibiotics in patients undergoing endoscopic ultrasound-directed transgastric interventions in Roux-en-Y gastric bypass and endoscopic ultrasound gastroenterostomy.

Gastrointestinal endoscopy·2026

Related Experiment Video

Updated: May 23, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Endotherapy for Barrett's esophagus.

Vani J A Konda1, Irving Waxman

  • 1Section of Gastroenterology, Center for Endoscopic Research and Therapeutics, University of Chicago Medical Center, Illinois, USA.

The American Journal of Gastroenterology
|April 11, 2012
PubMed
Summary

Endoscopic therapy is the primary treatment for Barrett's esophagus neoplasia. Early detection via high-resolution endoscopy and tailored treatments like endoscopic mucosal resection are key for patient management and surveillance.

More Related Videos

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy
04:05

Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy

Published on: August 22, 2025

Related Experiment Videos

Last Updated: May 23, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy
04:05

Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy

Published on: August 22, 2025

Area of Science:

  • Gastroenterology
  • Endoscopic Medicine

Background:

  • Barrett's esophagus (BE) is a precursor to esophageal adenocarcinoma.
  • Neoplasia in BE requires timely and effective endoscopic intervention.

Purpose of the Study:

  • To outline the current standard of care for managing neoplasia in BE.
  • To discuss the role of various endoscopic modalities in diagnosis and treatment.
  • To highlight areas for future research and guideline development.

Main Methods:

  • High-resolution white light endoscopy for neoplasia detection.
  • Endoscopic mucosal resection for visible lesions and histological diagnosis.
  • Ablative therapy for remaining epithelium post-resection.
  • Patient counseling and endoscopic workup are essential.

Main Results:

  • Endotherapy is the current mainstay for Barrett's associated neoplasia.
  • Accurate histological diagnosis via endoscopic mucosal resection is crucial.
  • Further validation is needed for enhanced imaging modalities.
  • Risk stratification is necessary before ablative therapy for nondysplastic BE.

Conclusions:

  • Endoscopic management is central to treating BE neoplasia.
  • Continued research on advanced imaging, treatment modalities, and risk stratification is vital.
  • Improved surveillance guidelines post-therapy are needed.